Supplementary Table 1 from The Nuclear Pool of Tetraspanin CD9 Contributes to Mitotic Processes in Human Breast Carcinoma

Characteristics of patients with ductal carcinoma of the breast. Nuclear CD9 ratios of patients with different stages of ductal breast carcinomas.</p

Supplementary Figure 1 from The Nuclear Pool of Tetraspanin CD9 Contributes to Mitotic Processes in Human Breast Carcinoma

Nuclear localization of CD9 in MA-11 and MCF-7 cells.</p

Supplementary Figure Legends from The Nuclear Pool of Tetraspanin CD9 Contributes to Mitotic Processes in Human Breast Carcinoma

Supplementary Figure Legends from The Nuclear Pool of Tetraspanin CD9 Contributes to Mitotic Processes in Human Breast Carcinom

Supplementary Figure 5 from The Nuclear Pool of Tetraspanin CD9 Contributes to Mitotic Processes in Human Breast Carcinoma

Nuclear expression of CD9 in breast cancer patients employing an anti-CD9 mAb against a different epitope.</p

Supplementary Figure 4 from The Nuclear Pool of Tetraspanin CD9 Contributes to Mitotic Processes in Human Breast Carcinoma

Abrogation of CD9 expression in MDA-CD9sh cells.</p

Supplementary Figure 2 from The Nuclear Pool of Tetraspanin CD9 Contributes to Mitotic Processes in Human Breast Carcinoma

Lack of a nuclear CD9 pool in HuMEC.</p

Supplementary Figure 3 from The Nuclear Pool of Tetraspanin CD9 Contributes to Mitotic Processes in Human Breast Carcinoma

MDA, MA-11 and MCF-7 cells do not have a nuclear pool of CD44.</p